+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anatomic Pathology Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

  • Report

  • 100 Pages
  • December 2020
  • Region: Global
  • Infinium Global Research
  • ID: 5235846
The report on the global anatomic pathology testing market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global anatomic pathology testing market to grow with a CAGR of 5.61% over the forecast period from 2020-2026. The study on anatomic pathology testing market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on anatomic pathology testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global anatomic pathology testing market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global anatomic pathology testing market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rising reliance on biomarkers-based pathology tests and processes to explore common malignancy and tumorigenesis is boosting the anatomic pathology testing market
  • High usage of advanced pathology equipment, for example, staining systems, gross imaging, and digital microscopes are poised to expand anatomically pathological practices to a major extent

2) Restraints
  • A lack of skilled professionals may hinder the market growth

3) Opportunities
  • An increasing number of clinical trials pertaining to cancer drugs provides lucrative opportunities for the market

Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global anatomic pathology testing market is segmented on the basis of component, and application.

The Global Anatomic Pathology Testing Market by Component
  • Instruments
  • Consumables
  • Services

The Global Anatomic Pathology Testing Market by Application
  • Disease Diagnosis
  • Drug Discovery & Development
  • Other Applications

Company Profiles
The companies covered in the report include
  • Sakura Finetechnical Co., Ltd.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • Agilent Technologies
  • Danaher Corporation
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Abbott Diagnostics
  • Advanced Cell Diagnostics

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the anatomic pathology testing market.
2. Complete coverage of all the segments in the anatomic pathology testing market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global anatomic pathology testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Anatomic Pathology Testing Market Highlights
2.2. Anatomic Pathology Testing Market Projection
2.3. Anatomic Pathology Testing Market Regional Highlights
3. Global Anatomic Pathology Testing Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Anatomic Pathology Testing Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Component
3.5.2. Growth Matrix Analysis by Application
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Anatomic Pathology Testing Market
4. Anatomic Pathology Testing Market Macro Indicator Analysis
5. Global Anatomic Pathology Testing Market by Component
5.1. Instruments
5.2. Consumables
5.3. Services
6. Global Anatomic Pathology Testing Market by Application
6.1. Disease Diagnosis
6.2. Drug Discovery & Development
6.3. Other Applications
7. Global Anatomic Pathology Testing Market by Region 2020-2026
7.1. North America
7.1.1. North America Anatomic Pathology Testing Market by Component
7.1.2. North America Anatomic Pathology Testing Market by Application
7.1.3. North America Anatomic Pathology Testing Market by Country
7.2. Europe
7.2.1. Europe Anatomic Pathology Testing Market by Component
7.2.2. Europe Anatomic Pathology Testing Market by Application
7.2.3. Europe Anatomic Pathology Testing Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Anatomic Pathology Testing Market by Component
7.3.2. Asia-Pacific Anatomic Pathology Testing Market by Application
7.3.3. Asia-Pacific Anatomic Pathology Testing Market by Country
7.4. RoW
7.4.1. RoW Anatomic Pathology Testing Market by Component
7.4.2. RoW Anatomic Pathology Testing Market by Application
7.4.3. RoW Anatomic Pathology Testing Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Anatomic Pathology Testing Market
8.2. Companies Profiled
8.2.1. Sakura Finetechnical Co., Ltd.
8.2.2. Quest Diagnostics Incorporated
8.2.3. Laboratory Corporation of America Holdings
8.2.4. NeoGenomics Laboratories, Inc.
8.2.5. Agilent Technologies
8.2.6. Danaher Corporation
8.2.7. Thermo Fisher Scientific
8.2.8. F. Hoffmann-La Roche AG
8.2.9. Abbott Diagnostics
8.2.10. Advanced Cell Diagnostics

Companies Mentioned

  • Sakura Finetechnical Co., Ltd.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • Agilent Technologies
  • Danaher Corporation
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche AG
  • Abbott Diagnostics
  • Advanced Cell Diagnostics